Condition: Non-Muscle Invasive Bladder Carcinoma

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07474519

Sponsor: Ohio State University Comprehensive Cancer Center

Phase: Phase 4

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Patient with intermediate or high risk NMIBC opting for intravesical induction BCG
• Has not initiated induction therapy
• Able to remain in supine position for two hours. (Head may be raised on up to two pillows)
• Able to remain in a sitting position for two hours
• Willingness to utilize a wearable fitness tracker for at least five days during the study
• Able to perform a remote video or telephone encounter
• Able to provide informed consent

Exclusion Criteria:

• Receipt of intravesical BCG within the past 1 year
• Known inability to retain BCG
• History of urinary incontinence with a score of 3 or more on the Overactive Bladder Survey (OAB) urgency, urgency incontinence, or incontinence questions
• Refusal to wear a fitness tracker during a 24-hour baseline, during treatment, and/or for 2 hours post treatment

View trial on ClinicalTrials.gov